首页 > 最新文献

Interdisciplinary cardiovascular and thoracic surgery最新文献

英文 中文
Cystic Fluorodeoxyglucose-Avid Thymic Hyperplasia with Lymphoepithelial Sialadenitis-like Features. 囊性氟脱氧葡萄糖胸腺增生伴淋巴上皮涎腺炎样特征。
0 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1093/icvts/ivaf297
Mahiro Ishizumi, Yoshito Yamada, Shinsuke Shibuya, Akihiro Aoyama

Thymic hyperplasia with lymphoepithelial sialadenitis-like features (LESA-like TH) is a rare benign thymic lesion sometimes associated with autoimmune diseases or mucosa-associated lymphoid tissue lymphoma. A 47-year-old man was incidentally found to have 2 anterior mediastinal masses. Contrast-enhanced computed tomography (CT) showed irregularly walled cysts, and positron emission tomography-CT demonstrated partial fluorodeoxyglucose (FDG) uptake. A total thymectomy was performed, and histopathology confirmed LESA-like TH. This is the first report to document both imaging-visible multiplicity and FDG avidity in LESA-like TH, which broadens the recognized imaging spectrum of this rare thymic lesion.

胸腺增生伴淋巴上皮涎腺炎样特征(lesa样TH)是一种罕见的胸腺良性病变,有时与自身免疫性疾病或粘膜相关淋巴组织淋巴瘤有关。一位47岁的男性偶然发现有两个前纵隔肿块。对比增强计算机断层扫描显示不规则壁囊肿,正电子发射断层扫描显示部分氟脱氧葡萄糖(FDG)摄取。行全胸腺切除术,组织病理学证实为lesa样TH。这是第一个记录lesa样TH成像可见多样性和FDG贪婪度的报告,这拓宽了这种罕见胸腺病变的公认成像谱。
{"title":"Cystic Fluorodeoxyglucose-Avid Thymic Hyperplasia with Lymphoepithelial Sialadenitis-like Features.","authors":"Mahiro Ishizumi, Yoshito Yamada, Shinsuke Shibuya, Akihiro Aoyama","doi":"10.1093/icvts/ivaf297","DOIUrl":"10.1093/icvts/ivaf297","url":null,"abstract":"<p><p>Thymic hyperplasia with lymphoepithelial sialadenitis-like features (LESA-like TH) is a rare benign thymic lesion sometimes associated with autoimmune diseases or mucosa-associated lymphoid tissue lymphoma. A 47-year-old man was incidentally found to have 2 anterior mediastinal masses. Contrast-enhanced computed tomography (CT) showed irregularly walled cysts, and positron emission tomography-CT demonstrated partial fluorodeoxyglucose (FDG) uptake. A total thymectomy was performed, and histopathology confirmed LESA-like TH. This is the first report to document both imaging-visible multiplicity and FDG avidity in LESA-like TH, which broadens the recognized imaging spectrum of this rare thymic lesion.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12782736/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145703064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Left-Handed Cardiac Surgery Learning Lab: An EACTS Annual Meeting Initiative. 左撇子心脏外科学习实验室:EACTS年会倡议。
0 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1093/icvts/ivaf279
Eric E Vinck, Mona Bickel-Dabadghao, Alicja Zientara, Anna Lena Emrich, Nora Göbel, Sabine Bleiziffer, Peyman Sardari Nia, Roman Gottardi

Left-handed cardiac surgery has been a rising topic. Training necessities pertaining to left-handed cardiac surgery education and mentorship are crucial to this group of surgeons. Through initiatives of experienced left-handed cardiac surgeons in association with the EACTS, a left-handed learning lab at the EACTS annual meeting was developed. This skills lab training is dedicated to offering left-handed surgeons a space which offers both technical development and career networking. In this short communication, we detail lessons learned and future insights into left-handed cardiac surgery education through hands-on training.

左撇子心脏手术一直是一个新兴的话题。关于左撇子心脏手术教育和指导的培训需求对这组外科医生至关重要。通过与EACTS联合的经验丰富的左撇子心脏外科医生的倡议,在EACTS年会上建立了一个左撇子学习实验室。这个技能实验室培训致力于为左撇子外科医生提供一个既提供技术发展又提供职业网络的空间。在这篇简短的文章中,我们详细介绍了通过实践培训进行左撇子心脏手术教育的经验教训和未来的见解。
{"title":"Left-Handed Cardiac Surgery Learning Lab: An EACTS Annual Meeting Initiative.","authors":"Eric E Vinck, Mona Bickel-Dabadghao, Alicja Zientara, Anna Lena Emrich, Nora Göbel, Sabine Bleiziffer, Peyman Sardari Nia, Roman Gottardi","doi":"10.1093/icvts/ivaf279","DOIUrl":"10.1093/icvts/ivaf279","url":null,"abstract":"<p><p>Left-handed cardiac surgery has been a rising topic. Training necessities pertaining to left-handed cardiac surgery education and mentorship are crucial to this group of surgeons. Through initiatives of experienced left-handed cardiac surgeons in association with the EACTS, a left-handed learning lab at the EACTS annual meeting was developed. This skills lab training is dedicated to offering left-handed surgeons a space which offers both technical development and career networking. In this short communication, we detail lessons learned and future insights into left-handed cardiac surgery education through hands-on training.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12782738/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145643334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronary Artery Bypass Surgery in Patients on Dialysis: In-Hospital Outcomes from UK Registry Analysis. 透析患者的冠状动脉旁路手术:来自英国登记分析的住院结果
0 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1093/icvts/ivaf291
Muhammed A Mashat, Tim Dong, Rahul Kota, Ettorino Di Tommaso, Pradeep Narayan, Charles Tan, Cha Rajakaruna, Eltayeb Mohamed Ahmed, Gianni D Angelini, Daniel P Fudulu

Objectives: Chronic kidney disease requiring dialysis significantly increases the risks of coronary artery disease. However, there is limited data on this high-risk patient population requiring coronary artery bypass grafting. Using a UK national registry, we investigated the impact of preoperative dialysis on in-hospital mortality and early morbidity in patients undergoing coronary artery bypass graft (CABG).

Methods: A retrospective analysis of National Adult Cardiac Surgery Audit data between January 1996, 2, and March 31, 2019, identified patients who underwent first-time isolated CABG. Propensity matching was performed to balance the baseline characteristics between dialysis and non-dialysis patients, yielding 633 matched pairs. We evaluated trends in CABG among dialysis patients and EuroSCORE 2 performance in predicting in-hospital mortality (calibration, discrimination, and clinical utility).

Results: There was a steep increase in CABG operations in dialysis patients after 2011. EuroSCORE 2 showed poor calibration, discrimination, and minimal clinical benefit in predicting mortality in dialysis cases. Dialysis patients exhibited a significantly higher in-hospital mortality rate (7.9% vs 2.1%, P < .001) than non-dialysis patients. The dialysis patients had longer median hospital stays (12 vs 9 days, P < .001) and a higher rate of return to the theatre for bleeding (5.5% vs 2.7%, P = .034). We found no difference in postoperative neurological deficit rates between the 2 cohorts. The odds ratio of in-hospital mortality for the dialysis vs non-dialysis patients was 4.62, P < .001, 95% (CI: 2.54-8.4). Significant predictors of mortality in the dialysis CABG cohort included advanced age (OR: 2.48), New York Heart Association class IV (OR: 3.06), and pulmonary hypertension (OR: 11.91).

Conclusions: There has been an overall increase in coronary artery bypass operations performed in renal dialysis-dependent patients in the UK. Preoperative chronic dialysis is associated with considerable in-hospital mortality, return to theatre for bleeding and prolonged hospital stay. EuroSCORE 2 has poor predictive performance in this patient cohort.

目的:需要透析的慢性肾脏疾病显著增加冠状动脉疾病的风险。然而,需要冠状动脉旁路移植术的高危患者的数据有限。使用英国国家登记处,我们调查了术前透析对行CABG患者住院死亡率和早期发病率的影响。方法:回顾性分析1996年2月1日至2019年3月31日全国成人心脏外科审计数据,确定首次行孤立性冠脉搭桥的患者。进行倾向匹配以平衡透析和非透析患者之间的基线特征,产生633对匹配。我们评估了透析患者CABG的趋势和EuroSCORE 2在预测院内死亡率方面的表现(校准、区分和临床效用)。结果:2011年后透析患者冠脉搭桥手术急剧增加。EuroSCORE 2在预测透析病例死亡率方面显示出较差的校准、区分和最小的临床获益。透析患者的住院死亡率明显更高(7.9% vs 2.1%)。结论:在英国,依赖肾脏透析的患者进行冠状动脉搭桥手术的总体增加。术前慢性透析与相当大的院内死亡率、因出血返回手术室和住院时间延长有关。EuroScore 2在该患者队列中的预测性能较差。
{"title":"Coronary Artery Bypass Surgery in Patients on Dialysis: In-Hospital Outcomes from UK Registry Analysis.","authors":"Muhammed A Mashat, Tim Dong, Rahul Kota, Ettorino Di Tommaso, Pradeep Narayan, Charles Tan, Cha Rajakaruna, Eltayeb Mohamed Ahmed, Gianni D Angelini, Daniel P Fudulu","doi":"10.1093/icvts/ivaf291","DOIUrl":"10.1093/icvts/ivaf291","url":null,"abstract":"<p><strong>Objectives: </strong>Chronic kidney disease requiring dialysis significantly increases the risks of coronary artery disease. However, there is limited data on this high-risk patient population requiring coronary artery bypass grafting. Using a UK national registry, we investigated the impact of preoperative dialysis on in-hospital mortality and early morbidity in patients undergoing coronary artery bypass graft (CABG).</p><p><strong>Methods: </strong>A retrospective analysis of National Adult Cardiac Surgery Audit data between January 1996, 2, and March 31, 2019, identified patients who underwent first-time isolated CABG. Propensity matching was performed to balance the baseline characteristics between dialysis and non-dialysis patients, yielding 633 matched pairs. We evaluated trends in CABG among dialysis patients and EuroSCORE 2 performance in predicting in-hospital mortality (calibration, discrimination, and clinical utility).</p><p><strong>Results: </strong>There was a steep increase in CABG operations in dialysis patients after 2011. EuroSCORE 2 showed poor calibration, discrimination, and minimal clinical benefit in predicting mortality in dialysis cases. Dialysis patients exhibited a significantly higher in-hospital mortality rate (7.9% vs 2.1%, P < .001) than non-dialysis patients. The dialysis patients had longer median hospital stays (12 vs 9 days, P < .001) and a higher rate of return to the theatre for bleeding (5.5% vs 2.7%, P = .034). We found no difference in postoperative neurological deficit rates between the 2 cohorts. The odds ratio of in-hospital mortality for the dialysis vs non-dialysis patients was 4.62, P < .001, 95% (CI: 2.54-8.4). Significant predictors of mortality in the dialysis CABG cohort included advanced age (OR: 2.48), New York Heart Association class IV (OR: 3.06), and pulmonary hypertension (OR: 11.91).</p><p><strong>Conclusions: </strong>There has been an overall increase in coronary artery bypass operations performed in renal dialysis-dependent patients in the UK. Preoperative chronic dialysis is associated with considerable in-hospital mortality, return to theatre for bleeding and prolonged hospital stay. EuroSCORE 2 has poor predictive performance in this patient cohort.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12782734/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145672963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myocardial Protection Efficacy of Custodiol, Del Nido, and Cold Intermittent Blood Cardioplegia in Arterial Switch Operation. 全内窥镜二尖瓣手术同时左侧冷冻消融的远期疗效。
0 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1093/icvts/ivaf215
Mustafa Kemal Avşar, Yasin Güzel, Barış Kırat, İbrahim Özgür Önsel, Cenap Zeybek, Deniz Yorgancılar, İlker Kemal Yücel

Objectives: The arterial switch operation (ASO) is the standard treatment for transposition of the great arteries (TGA), requiring robust myocardial protection due to the neonatal myocardium's vulnerability to ischaemia. This study compares the myocardial protective efficacy of Custodiol, Del Nido, and cold intermittent blood cardioplegia in neonates undergoing ASO.

Methods: We retrospectively analysed 133 neonates with TGA undergoing ASO (2013-2024) at 4 Turkish centres, grouped by cardioplegia: cold blood (n = 47), Custodiol (n = 44), or Del Nido (n = 42). Outcomes included aortic cross-clamp and cardiopulmonary bypass times, troponin I, CK-MB, inotropic support, and ventilation duration.

Results: Custodiol and Del Nido had shorter cross-clamp (70.4 (8.5) vs 68.7 (7.9) vs 78.2 (9.1) minutes, P < .001) and bypass times (P = .004), lower troponin I (4.2 (1.3) vs 4.0 (1.5) vs 6.8 (1.9) ng/mL, P < .001), reduced inotropic needs (P < .001), and shorter ventilation/intensive care unit stays (P ≤ .010). Mortality was similar (P = .47).

Conclusions: Custodiol and Del Nido cardioplegia strategies provided favourable outcomes compared to cold blood cardioplegia in neonates undergoing ASO, with implications for optimizing myocardial protection protocols in this population.

目的:合并心房颤动消融是二尖瓣手术患者的一种完善的治疗方法。然而,关于在全内窥镜二尖瓣手术中进行冷冻消融的长期结果的数据仍然有限。此外,不同的病变组和内镜入路使用的能量来源可能导致不同的结果。因此,我们分析了在全内窥镜二尖瓣手术中接受左侧冷冻消融的患者的节律结果。方法:选取2016年至2023年在我中心行全内窥镜二尖瓣手术合并左侧冷冻消融的患者。回顾性数据分析基于24小时动态心电图监测随访数据。结果:共纳入123例患者。没有观察到消融过程相关的并发症。中位随访期为36.0个月(四分位数间距:17-60个月)。在此期间,34次房颤复发被记录下来,对应的复发率为8.43 / 100患者-年(95%置信区间:5.90 - 11.73)。1年、3年和5年的AF自由度分别为96.6%、86.3%和69.4%。房颤类型(p = 0.004;危险比[HR]: 2.521; 95%可信区间[CI]: 1.347-4.716)和左房容积(p = 0.003;危险比:1.010;95% CI: 1.003-1.016)被确定为房颤复发的预测因素。结论:在全内窥镜二尖瓣手术中同时行左侧冷冻消融是一种安全有效的治疗心房颤动的方法。令人鼓舞的长期结果支持在全内窥镜二尖瓣手术中考虑这种入路。
{"title":"Myocardial Protection Efficacy of Custodiol, Del Nido, and Cold Intermittent Blood Cardioplegia in Arterial Switch Operation.","authors":"Mustafa Kemal Avşar, Yasin Güzel, Barış Kırat, İbrahim Özgür Önsel, Cenap Zeybek, Deniz Yorgancılar, İlker Kemal Yücel","doi":"10.1093/icvts/ivaf215","DOIUrl":"10.1093/icvts/ivaf215","url":null,"abstract":"<p><strong>Objectives: </strong>The arterial switch operation (ASO) is the standard treatment for transposition of the great arteries (TGA), requiring robust myocardial protection due to the neonatal myocardium's vulnerability to ischaemia. This study compares the myocardial protective efficacy of Custodiol, Del Nido, and cold intermittent blood cardioplegia in neonates undergoing ASO.</p><p><strong>Methods: </strong>We retrospectively analysed 133 neonates with TGA undergoing ASO (2013-2024) at 4 Turkish centres, grouped by cardioplegia: cold blood (n = 47), Custodiol (n = 44), or Del Nido (n = 42). Outcomes included aortic cross-clamp and cardiopulmonary bypass times, troponin I, CK-MB, inotropic support, and ventilation duration.</p><p><strong>Results: </strong>Custodiol and Del Nido had shorter cross-clamp (70.4 (8.5) vs 68.7 (7.9) vs 78.2 (9.1) minutes, P < .001) and bypass times (P = .004), lower troponin I (4.2 (1.3) vs 4.0 (1.5) vs 6.8 (1.9) ng/mL, P < .001), reduced inotropic needs (P < .001), and shorter ventilation/intensive care unit stays (P ≤ .010). Mortality was similar (P = .47).</p><p><strong>Conclusions: </strong>Custodiol and Del Nido cardioplegia strategies provided favourable outcomes compared to cold blood cardioplegia in neonates undergoing ASO, with implications for optimizing myocardial protection protocols in this population.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12782733/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145132620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgically Treated Left Ventricular Myxomas: A 75-Year Systematic Review of Patient Demographics, Tumour Characteristics, and Outcomes. 手术治疗左心室黏液瘤:75年患者人口统计学、肿瘤特征和结果的系统回顾。
0 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1093/icvts/ivaf248
Hamza A Abdul-Hafez, Asmaa Sarama, Tammah Safadi, Mahmoud N Khadra, Hasan Husni Salman, Ahmad K Darwazah, Hasan Alkhatib

Objectives: Cardiac myxomas are rare primary heart tumours, most commonly originating in the left atrium. A smaller proportion occurs in the left ventricle, where they are even more uncommon and present unique diagnostic and therapeutic challenges. This systematic review aims to characterize the clinical features, management strategies, and outcomes of left ventricular cardiac myxomas.

Methods: A systematic search of the PubMed database was conducted to identify articles published up to May 2025. A total of 174 cases of surgically treated left ventricular myxomas were included. Data were extracted on patient demographics, tumour characteristics, surgical approaches, and follow-up outcomes.

Results: Patients showed a broad geographic distribution, with the highest number of cases reported from the United States. The mean age was 38.2 ± 20.37 years, with a slight female predominance (48.9%). Tumours were most commonly attached to the left ventricular wall (43.7%) and inter-ventricular septum (25.3%). Complete surgical excision was achieved in 92.5% of cases and was strongly associated with survival; nearly all patients with complete resection survived, compared to only 20% among those without. Overall postoperative survival was high (83.9%), with a low mortality rate (2.9%). Survival rates were comparable across genders and age groups, although paediatric patients had a slightly higher mortality rate (9.1%).

Conclusions: This systematic review represents the most comprehensive analysis to date of surgically treated left ventricular myxomas. The findings highlight the importance of complete excision in achieving favourable outcomes and highlight demographic and geographic patterns that can inform clinical suspicion, surgical planning, and patient counselling.

目的:心脏黏液瘤是一种罕见的原发性心脏肿瘤,最常发源于左心房。发生在左心室的比例较小,在那里更不常见,并提出了独特的诊断和治疗挑战。本系统综述旨在描述左心室心脏黏液瘤的临床特征、治疗策略和预后。方法:对PubMed数据库进行系统检索,确定2025年5月之前发表的文章。本研究共包括174例经手术治疗的左心室黏液瘤。提取患者人口统计学、肿瘤特征、手术入路和随访结果的数据。结果:患者具有广泛的地理分布,美国报告的病例数最多。平均年龄38.2 ± 20.37岁,女性略占优势(48.9%)。肿瘤最常见于左室壁(43.7%)和室间隔(25.3%)。92.5%的病例实现了完全手术切除,并与生存率密切相关;几乎所有完全切除的患者都存活了下来,而没有切除的患者只有20%。术后总生存率高(83.9%),死亡率低(2.9%)。尽管儿科患者的死亡率略高(9.1%),但不同性别和年龄组的生存率具有可比性。结论:本系统综述是迄今为止手术治疗左心室黏液瘤最全面的分析。研究结果强调了完全切除对获得良好结果的重要性,并强调了可以为临床怀疑、手术计划和患者咨询提供信息的人口和地理模式。
{"title":"Surgically Treated Left Ventricular Myxomas: A 75-Year Systematic Review of Patient Demographics, Tumour Characteristics, and Outcomes.","authors":"Hamza A Abdul-Hafez, Asmaa Sarama, Tammah Safadi, Mahmoud N Khadra, Hasan Husni Salman, Ahmad K Darwazah, Hasan Alkhatib","doi":"10.1093/icvts/ivaf248","DOIUrl":"10.1093/icvts/ivaf248","url":null,"abstract":"<p><strong>Objectives: </strong>Cardiac myxomas are rare primary heart tumours, most commonly originating in the left atrium. A smaller proportion occurs in the left ventricle, where they are even more uncommon and present unique diagnostic and therapeutic challenges. This systematic review aims to characterize the clinical features, management strategies, and outcomes of left ventricular cardiac myxomas.</p><p><strong>Methods: </strong>A systematic search of the PubMed database was conducted to identify articles published up to May 2025. A total of 174 cases of surgically treated left ventricular myxomas were included. Data were extracted on patient demographics, tumour characteristics, surgical approaches, and follow-up outcomes.</p><p><strong>Results: </strong>Patients showed a broad geographic distribution, with the highest number of cases reported from the United States. The mean age was 38.2 ± 20.37 years, with a slight female predominance (48.9%). Tumours were most commonly attached to the left ventricular wall (43.7%) and inter-ventricular septum (25.3%). Complete surgical excision was achieved in 92.5% of cases and was strongly associated with survival; nearly all patients with complete resection survived, compared to only 20% among those without. Overall postoperative survival was high (83.9%), with a low mortality rate (2.9%). Survival rates were comparable across genders and age groups, although paediatric patients had a slightly higher mortality rate (9.1%).</p><p><strong>Conclusions: </strong>This systematic review represents the most comprehensive analysis to date of surgically treated left ventricular myxomas. The findings highlight the importance of complete excision in achieving favourable outcomes and highlight demographic and geographic patterns that can inform clinical suspicion, surgical planning, and patient counselling.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12782727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145304792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-Port Robotics and the Changing Landscape of Thoracic Surgery. 单端口机器人技术和胸外科手术的变化。
0 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1093/icvts/ivaf292
Shyam Sundar Sah, Abhishek Kumbhalwar
{"title":"Single-Port Robotics and the Changing Landscape of Thoracic Surgery.","authors":"Shyam Sundar Sah, Abhishek Kumbhalwar","doi":"10.1093/icvts/ivaf292","DOIUrl":"10.1093/icvts/ivaf292","url":null,"abstract":"","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12782740/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145679697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Hydrogel-Coated Chest Drains on Outcomes in Thoracic Surgery. 水凝胶包被胸腔引流管对胸外科预后的影响。
0 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1093/icvts/ivaf290
Akshay J Patel, Stefano Cafarotti, Thomas Kiefer, Francesco Leo, Puiyee Sophia Chan, Federico Femia, Adele Tessitore, Miriam Patella, Simona Sobrero, Andrea Bille

Objectives: To compare postoperative outcomes between hydrogel-coated chest drains (HCDs) and conventional non-coated drains (NCDs) in patients undergoing general thoracic surgery, using a propensity score-matched analysis.

Methods: This retrospective multi-institutional study included adult patients who underwent thoracic surgery across 4 European centres between February and September 2022. Patients were grouped according to drain type (HCD vs NCD), and a propensity score-matched analysis was performed to account for 16 preoperative and intraoperative covariates. The primary outcome was length of postoperative hospital stay (LOS). Secondary outcomes included in-hospital complications, intensive care unit (ICU) admission, chest drain reinsertion, readmission, duration of drainage, and in-hospital mortality. Subgroup analysis was performed in patients undergoing anatomical lung resections.

Results: A total of 773 patients were included (HCD n = 362; NCD n = 411). After matching, 724 patients were analysed. HCD use was associated with a significantly shorter LOS (average treatment effect of the treated population -1.87 days; 95% CI -3.04 to -0.695; P = .002), lower odds of ICU admission (odds ratio [OR] 0.29; 95% CI 0.16-0.53; P < .001), and lower in-hospital complication rates (OR 0.38; 95% CI 0.26-0.55; P < .001). Rates of pneumonia (5.2% vs 13.4%; P = .001), atrial fibrillation (2.2% vs 9.0%; P < .001), and retained pleural effusion (0.8% vs 3.6%; P = .015) were significantly lower in the HCD group. There were no significant differences in drain duration, readmission, or mortality. In the anatomical resection subgroup, HCDs were similarly associated with reduced LOS and complications.

Conclusions: Hydrogel-coated drains are associated with fewer postoperative complications and shorter hospital stay compared to conventional drains, particularly in anatomical lung resections. These findings support further prospective evaluation to define the role of HCDs in routine thoracic surgical practice.

目的:通过倾向评分匹配分析,比较普通胸外科患者水凝胶包被胸管(hcd)和常规非包被胸管(ncd)的术后结果。方法:这项回顾性多机构研究包括在2022年2月至9月期间在四个欧洲中心接受胸外科手术的成年患者。根据引流类型(HCD vs NCD)对患者进行分组,并进行倾向评分匹配分析,以解释16个术前和术中协变量。主要观察指标为术后住院时间(LOS)。次要结局包括院内并发症、ICU入院、胸腔引流管重新插入、再入院、引流时间(LOD)和院内死亡率。对解剖性肺切除术患者进行亚组分析。结果:共纳入773例患者(HCD n = 362; NCD n = 411)。匹配后,对724例患者进行分析。HCD的使用与较短的LOS (ATT -1.87天;95% CI -3.04至-0.695;p = 0.002)、较低的ICU入院几率(OR 0.29; 95% CI 0.16-0.53; p)相关,结论:与常规引流管相比,水凝胶涂层引流管术后并发症较少,住院时间更短,特别是在解剖性肺切除术中。这些发现支持进一步的前瞻性评估,以确定hcd在常规胸外科实践中的作用。
{"title":"Impact of Hydrogel-Coated Chest Drains on Outcomes in Thoracic Surgery.","authors":"Akshay J Patel, Stefano Cafarotti, Thomas Kiefer, Francesco Leo, Puiyee Sophia Chan, Federico Femia, Adele Tessitore, Miriam Patella, Simona Sobrero, Andrea Bille","doi":"10.1093/icvts/ivaf290","DOIUrl":"10.1093/icvts/ivaf290","url":null,"abstract":"<p><strong>Objectives: </strong>To compare postoperative outcomes between hydrogel-coated chest drains (HCDs) and conventional non-coated drains (NCDs) in patients undergoing general thoracic surgery, using a propensity score-matched analysis.</p><p><strong>Methods: </strong>This retrospective multi-institutional study included adult patients who underwent thoracic surgery across 4 European centres between February and September 2022. Patients were grouped according to drain type (HCD vs NCD), and a propensity score-matched analysis was performed to account for 16 preoperative and intraoperative covariates. The primary outcome was length of postoperative hospital stay (LOS). Secondary outcomes included in-hospital complications, intensive care unit (ICU) admission, chest drain reinsertion, readmission, duration of drainage, and in-hospital mortality. Subgroup analysis was performed in patients undergoing anatomical lung resections.</p><p><strong>Results: </strong>A total of 773 patients were included (HCD n = 362; NCD n = 411). After matching, 724 patients were analysed. HCD use was associated with a significantly shorter LOS (average treatment effect of the treated population -1.87 days; 95% CI -3.04 to -0.695; P = .002), lower odds of ICU admission (odds ratio [OR] 0.29; 95% CI 0.16-0.53; P < .001), and lower in-hospital complication rates (OR 0.38; 95% CI 0.26-0.55; P < .001). Rates of pneumonia (5.2% vs 13.4%; P = .001), atrial fibrillation (2.2% vs 9.0%; P < .001), and retained pleural effusion (0.8% vs 3.6%; P = .015) were significantly lower in the HCD group. There were no significant differences in drain duration, readmission, or mortality. In the anatomical resection subgroup, HCDs were similarly associated with reduced LOS and complications.</p><p><strong>Conclusions: </strong>Hydrogel-coated drains are associated with fewer postoperative complications and shorter hospital stay compared to conventional drains, particularly in anatomical lung resections. These findings support further prospective evaluation to define the role of HCDs in routine thoracic surgical practice.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12782731/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145656091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expanding Lung Volume Reduction Surgery Indications: Outcomes in Patients Beyond Conventional National Emphysema Treatment Trial Criteria. 扩大肺减容手术指征:超出常规NETT标准的患者的结果。
0 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1093/icvts/ivaf274
Christelle M Vandervelde, Anthony Meyers, Anaïs David, Sofian Bouneb, Stephanie Everaerts, Wim Janssens, Walter Weder, Laurens J Ceulemans

Objectives: Lung volume reduction surgery (LVRS) is guided by strict selection criteria from the National Emphysema Treatment Trial (NETT) to minimize risk and optimize outcomes. However, emerging evidence suggests that rigid cutoffs may exclude patients who could benefit. This study aimed to identify beyond-criteria patients undergoing LVRS and compare their outcomes with standard-criteria patients.

Methods: This single-centre retrospective analysis of a prospectively maintained database included all LVRS procedures from August 2019 until November 2024. Patients were classified as beyond-criteria if they met two or more of the following: age ≥ 75 years, body mass index (BMI) < 18.5 kg/m2, forced expiratory volume in 1 second (FEV1) < 20%pred, diffusing capacity for carbon monoxide (DLCO) < 20%pred, 6-minute walk distance (6MWD) < 140 m, homogeneous emphysema, systolic pulmonary arterial pressure (sPAP) > 35 mmHg, or prior thoracic interventions. Complications (Clavien-Dindo) and functional outcomes were assessed at 3, 6, and 12 months.

Results: Twenty-one procedures were performed in 18 beyond-criteria patients versus 227 procedures in 191 standard-criteria patients. Among beyond-criteria patients: age ≥ 75 years (n = 3), BMI < 18.5 kg/m2 (n = 10), FEV1 < 20%pred (n = 5), DLCO < 20%pred (n = 1), 6MWD < 140 m (n = 1), homogeneous emphysema (n = 3), sPAP > 35 mmHg (n = 12), and prior thoracic intervention (n = 7). Complication rates were comparable (38% vs. 42%, P = .819 [95% CI, 0.93-1.10]), as were prolonged air leaks and hospital stay. One 30-day LVRS-related death (0.4%) occurred in the standard group. Functional and quality of life measures improved in both groups.

Conclusions: Beyond-criteria patients can be considered for LVRS when guided by careful multidisciplinary evaluation, with meaningful improvement in experienced centers.

目的:肺减容手术(LVRS)遵循国家肺气肿治疗试验(NETT)的严格选择标准,以最大限度地降低风险并优化结果。然而,新出现的证据表明,严格的界限可能会排除可能受益的患者。本研究旨在识别接受LVRS的超标准患者,并将其结果与标准患者进行比较。方法:对前瞻性维护的数据库进行单中心回顾性分析,包括2019年8月至2024年11月的所有LVRS手术。如果患者符合以下两项或多项标准,则将其归类为超出标准:年龄≥75岁,体重指数(BMI) 35mmhg,或既往胸部干预。在3、6和12个月时评估并发症(Clavien-Dindo)和功能结局。结果:18例非标准患者行21例手术,191例符合标准患者行227例手术。在超出标准的患者中:年龄≥75岁(n = 3), BMI 35 mmHg (n = 12),既往胸部干预(n = 7)。并发症发生率相当(38% vs 42%, p = 0.819 [95% CI 0.93-1.10]),延长的漏气时间和住院时间也是如此。标准组发生1例30天lvrs相关死亡(0.4%)。两组患者的功能和生活质量指标均有所改善。结论:在仔细的多学科评估指导下,可以考虑超出标准的患者进行LVRS,经验丰富的中心有意义的改善。
{"title":"Expanding Lung Volume Reduction Surgery Indications: Outcomes in Patients Beyond Conventional National Emphysema Treatment Trial Criteria.","authors":"Christelle M Vandervelde, Anthony Meyers, Anaïs David, Sofian Bouneb, Stephanie Everaerts, Wim Janssens, Walter Weder, Laurens J Ceulemans","doi":"10.1093/icvts/ivaf274","DOIUrl":"10.1093/icvts/ivaf274","url":null,"abstract":"<p><strong>Objectives: </strong>Lung volume reduction surgery (LVRS) is guided by strict selection criteria from the National Emphysema Treatment Trial (NETT) to minimize risk and optimize outcomes. However, emerging evidence suggests that rigid cutoffs may exclude patients who could benefit. This study aimed to identify beyond-criteria patients undergoing LVRS and compare their outcomes with standard-criteria patients.</p><p><strong>Methods: </strong>This single-centre retrospective analysis of a prospectively maintained database included all LVRS procedures from August 2019 until November 2024. Patients were classified as beyond-criteria if they met two or more of the following: age ≥ 75 years, body mass index (BMI) < 18.5 kg/m2, forced expiratory volume in 1 second (FEV1) < 20%pred, diffusing capacity for carbon monoxide (DLCO) < 20%pred, 6-minute walk distance (6MWD) < 140 m, homogeneous emphysema, systolic pulmonary arterial pressure (sPAP) > 35 mmHg, or prior thoracic interventions. Complications (Clavien-Dindo) and functional outcomes were assessed at 3, 6, and 12 months.</p><p><strong>Results: </strong>Twenty-one procedures were performed in 18 beyond-criteria patients versus 227 procedures in 191 standard-criteria patients. Among beyond-criteria patients: age ≥ 75 years (n = 3), BMI < 18.5 kg/m2 (n = 10), FEV1 < 20%pred (n = 5), DLCO < 20%pred (n = 1), 6MWD < 140 m (n = 1), homogeneous emphysema (n = 3), sPAP > 35 mmHg (n = 12), and prior thoracic intervention (n = 7). Complication rates were comparable (38% vs. 42%, P = .819 [95% CI, 0.93-1.10]), as were prolonged air leaks and hospital stay. One 30-day LVRS-related death (0.4%) occurred in the standard group. Functional and quality of life measures improved in both groups.</p><p><strong>Conclusions: </strong>Beyond-criteria patients can be considered for LVRS when guided by careful multidisciplinary evaluation, with meaningful improvement in experienced centers.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12782724/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145552307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Favourable Outcomes of Valve Repair in Congenital Heart Surgery. 先天性心脏手术中瓣膜修复的早期良好结果。
0 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1093/icvts/ivaf273
Muhammed Ikbal Aydin, Eiri Kisamori, Mitchell Haverty, Rittal Mehta, Aybala Tongut, Manan Desai, Gerard Martin, Wayne Jay Franklin, Yves d'Udekem

Objectives: Mechanical valve replacement is often used as the therapeutic option in valvular heart surgery in children. Evidence suggests that this should change to provide optimal long-term survival for this growing population. We reviewed our current practice in valve repair in congenital heart disease and analysed its outcomes.

Methods: A total of 90 patients (30 semilunar valve and 60 atrioventricular [AV] valve) underwent valve repair between September 2020 and December 2024. Operative data and follow-up information were gathered retrospectively. Kaplan-Meier calculations were used for survival and freedom from reoperation analysis. Cox regression analysis was used to assess risk factors for mortality (single ventricle physiology, age and weight at time of surgery, bicuspid aortic valve, and complexity of repair). Complexity of repair was defined as the application of 3 or more repair techniques.

Results: Estimated survival at 12 months for semilunar and AV valve groups was 95.2% and 95%, respectively. Estimated freedom from reoperation at 12 months for repair of semilunar and AV valves was 95.8% and 95.6%, respectively. Single ventricle morphology (HR [hazard ratio], 5.2; 95% confidence interval [CI], 1.3-20.8; P = .0198) and younger age at time of surgery (HR, 0.7; 95% CI, 0.6-0.9; P = .0223) were associated with increased risk of mortality.

Conclusions: Valve repair in congenital heart disease provides reliable early outcomes in this complex population. The worst outcomes are expected in patients with single ventricle requiring surgery in early life.

目的:在儿童心脏瓣膜手术中,机械瓣膜置换术是常用的治疗方法。有证据表明,这种情况应该改变,以便为不断增长的人口提供最佳的长期生存。我们回顾了目前在先天性心脏病瓣膜修复方面的实践,并分析了其结果。方法:在2020年9月至2024年12月期间,共90例患者(30例半月瓣,60例房室瓣)行瓣膜修复术。回顾性收集手术资料和随访资料。Kaplan-Meier计算用于生存和免于再手术分析。采用Cox回归分析评估死亡率的危险因素(单心室生理学、手术时的年龄和体重、二尖瓣主动脉瓣和修复复杂性)。修复的复杂性被定义为三种或三种以上修复技术的应用。结果:半月瓣组和房室瓣组12个月的估计生存率分别为95.2%和95%。估计12个月后半月瓣和房室瓣的再手术自由度分别为95.8%和95.6%。单心室形态(HR: 5.2, 95% CI: 1.3-20.8; p = 0.0198)和手术时年龄较小(HR: 0.7, 95% CI: 0.6-0.9; p = 0.0223)与死亡风险增加相关。结论:先天性心脏病的瓣膜修复在这一复杂人群中提供了可靠的早期结果。最坏的结果是在早期需要手术的单心室患者。
{"title":"Early Favourable Outcomes of Valve Repair in Congenital Heart Surgery.","authors":"Muhammed Ikbal Aydin, Eiri Kisamori, Mitchell Haverty, Rittal Mehta, Aybala Tongut, Manan Desai, Gerard Martin, Wayne Jay Franklin, Yves d'Udekem","doi":"10.1093/icvts/ivaf273","DOIUrl":"10.1093/icvts/ivaf273","url":null,"abstract":"<p><strong>Objectives: </strong>Mechanical valve replacement is often used as the therapeutic option in valvular heart surgery in children. Evidence suggests that this should change to provide optimal long-term survival for this growing population. We reviewed our current practice in valve repair in congenital heart disease and analysed its outcomes.</p><p><strong>Methods: </strong>A total of 90 patients (30 semilunar valve and 60 atrioventricular [AV] valve) underwent valve repair between September 2020 and December 2024. Operative data and follow-up information were gathered retrospectively. Kaplan-Meier calculations were used for survival and freedom from reoperation analysis. Cox regression analysis was used to assess risk factors for mortality (single ventricle physiology, age and weight at time of surgery, bicuspid aortic valve, and complexity of repair). Complexity of repair was defined as the application of 3 or more repair techniques.</p><p><strong>Results: </strong>Estimated survival at 12 months for semilunar and AV valve groups was 95.2% and 95%, respectively. Estimated freedom from reoperation at 12 months for repair of semilunar and AV valves was 95.8% and 95.6%, respectively. Single ventricle morphology (HR [hazard ratio], 5.2; 95% confidence interval [CI], 1.3-20.8; P = .0198) and younger age at time of surgery (HR, 0.7; 95% CI, 0.6-0.9; P = .0223) were associated with increased risk of mortality.</p><p><strong>Conclusions: </strong>Valve repair in congenital heart disease provides reliable early outcomes in this complex population. The worst outcomes are expected in patients with single ventricle requiring surgery in early life.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12782726/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145642985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Xu et al. 回复Xu等人。
0 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1093/icvts/ivaf284
Ruixin Lu, Michael Dismorr, Natalie Glaser, Ulrik Sartipy
{"title":"Reply to Xu et al.","authors":"Ruixin Lu, Michael Dismorr, Natalie Glaser, Ulrik Sartipy","doi":"10.1093/icvts/ivaf284","DOIUrl":"10.1093/icvts/ivaf284","url":null,"abstract":"","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12782739/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145656097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Interdisciplinary cardiovascular and thoracic surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1